As of 2025-10-14, the Intrinsic Value of HCA Healthcare Inc (HCA) is 476.90 USD. This HCA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 410.68 USD, the upside of HCA Healthcare Inc is 16.10%.
The range of the Intrinsic Value is 374.64 - 630.38 USD
Based on its market price of 410.68 USD and our intrinsic valuation, HCA Healthcare Inc (HCA) is undervalued by 16.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 374.64 - 630.38 | 476.90 | 16.1% |
| DCF (Growth 10y) | 443.73 - 707.20 | 549.53 | 33.8% |
| DCF (EBITDA 5y) | 350.83 - 490.44 | 401.53 | -2.2% |
| DCF (EBITDA 10y) | 435.94 - 601.66 | 499.46 | 21.6% |
| Fair Value | 389.41 - 389.41 | 389.41 | -5.18% |
| P/E | 371.76 - 517.05 | 446.07 | 8.6% |
| EV/EBITDA | 236.75 - 413.95 | 301.31 | -26.6% |
| EPV | 912.70 - 1,189.64 | 1,051.17 | 156.0% |
| DDM - Stable | 197.18 - 386.81 | 291.99 | -28.9% |
| DDM - Multi | 288.43 - 446.40 | 350.92 | -14.6% |
| Market Cap (mil) | 96,095.02 |
| Beta | 0.28 |
| Outstanding shares (mil) | 233.99 |
| Enterprise Value (mil) | 139,639.02 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.00% |
| Cost of Debt | 4.98% |
| WACC | 6.75% |